-
1
-
-
83955162930
-
Allergic rhinitis
-
Greiner A.N., Hellings P.W., Rotiroti G., Scadding G.K. Allergic rhinitis. Lancet 2011, 378:2112-2122.
-
(2011)
Lancet
, vol.378
, pp. 2112-2122
-
-
Greiner, A.N.1
Hellings, P.W.2
Rotiroti, G.3
Scadding, G.K.4
-
2
-
-
47749085883
-
The diagnosis and management of rhinitis: an updated practice parameter
-
Wallace D.V., Dykewicz M.S., Bernstein D.I., et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008, 122(Suppl 2):S1-S84.
-
(2008)
J Allergy Clin Immunol
, vol.122
, Issue.SUPPL. 2
-
-
Wallace, D.V.1
Dykewicz, M.S.2
Bernstein, D.I.3
-
3
-
-
0034912161
-
Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis
-
Skoner D.P. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 2001, 108(Suppl 1):S2-S8.
-
(2001)
J Allergy Clin Immunol
, vol.108
, Issue.SUPPL. 1
-
-
Skoner, D.P.1
-
4
-
-
0002885825
-
Allergic rhinitis and its impact on asthma
-
ARIA Workshop Group
-
Bousquet J. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001, 108:S147-S334. ARIA Workshop Group.
-
(2001)
J Allergy Clin Immunol
, vol.108
-
-
Bousquet, J.1
-
5
-
-
0032512287
-
Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials
-
Weiner J.M., Abramson M.J., Puy R.M. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 1998, 317:1624-1629.
-
(1998)
BMJ
, vol.317
, pp. 1624-1629
-
-
Weiner, J.M.1
Abramson, M.J.2
Puy, R.M.3
-
6
-
-
79953179336
-
Is there a role for aerosol nasal sprays in the treatment of allergic rhinitis
-
Luskin A.T., Blaiss M.S., Farrar J.R., et al. Is there a role for aerosol nasal sprays in the treatment of allergic rhinitis. Allergy Asthma Proc 2011, 32:168-177.
-
(2011)
Allergy Asthma Proc
, vol.32
, pp. 168-177
-
-
Luskin, A.T.1
Blaiss, M.S.2
Farrar, J.R.3
-
7
-
-
84859637120
-
Insights on allergic rhinitis from the patient perspective
-
Fromer L.M., Ortiz G., Ryan S.F., Stoloff S.W. Insights on allergic rhinitis from the patient perspective. J Fam Pract 2012, 61(Suppl 2):S16-S22.
-
(2012)
J Fam Pract
, vol.61
, Issue.SUPPL. 2
-
-
Fromer, L.M.1
Ortiz, G.2
Ryan, S.F.3
Stoloff, S.W.4
-
9
-
-
84862131674
-
-
[prescribing information], GlaxoSmithKline, Research Triangle Park, NC
-
Beconase AQ (beclomethasone dipropionate, monohydrate) nasal spray, 42 mcg 2005, [prescribing information], GlaxoSmithKline, Research Triangle Park, NC.
-
(2005)
Beconase AQ (beclomethasone dipropionate, monohydrate) nasal spray, 42 mcg
-
-
-
10
-
-
84872611438
-
-
Accessed September 28, 2011
-
Montreal Protocol Accessed September 28, 2011. http://www.epa.gov/ozone/intpol/.
-
Montreal Protocol
-
-
-
11
-
-
84862538560
-
-
[prescribing information], Teva Respiratory, LLC, Horsham, PA
-
QVAR 40 mcg (beclomethasone dipropionate HFA, 40 mcg) inhalation aerosol for oral inhalation only; QVAR 80 mcg (beclomethasone dipropionate HFA, 80 mcg) inhalation aerosol for oral inhalation only 2010, [prescribing information], Teva Respiratory, LLC, Horsham, PA.
-
(2010)
QVAR 40 mcg (beclomethasone dipropionate HFA, 40 mcg) inhalation aerosol for oral inhalation only; QVAR 80 mcg (beclomethasone dipropionate HFA, 80 mcg) inhalation aerosol for oral inhalation only
-
-
-
12
-
-
84862119417
-
Safety and efficacy of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with perennial allergic rhinitis
-
Meltzer E.O., Jacobs R.L., LaForce C.F., Kelley L., Dunbar S.A., Tantry S.K. Safety and efficacy of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with perennial allergic rhinitis. Allergy Asthma Proc 2012, 33:249-257.
-
(2012)
Allergy Asthma Proc
, vol.33
, pp. 249-257
-
-
Meltzer, E.O.1
Jacobs, R.L.2
LaForce, C.F.3
Kelley, L.4
Dunbar, S.A.5
Tantry, S.K.6
-
13
-
-
0034854302
-
Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man
-
Daley-Yates P.T., Price A.C., Sisson J.R., Pereira A., Dallow N. Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. Br J Clin Pharmacol 2001, 51:400-409.
-
(2001)
Br J Clin Pharmacol
, vol.51
, pp. 400-409
-
-
Daley-Yates, P.T.1
Price, A.C.2
Sisson, J.R.3
Pereira, A.4
Dallow, N.5
-
14
-
-
0031837092
-
Beclomethasone relative availability of oral versus inhaled beclomethasone dipropionate from an HFA-134A metered dose inhaler
-
Soria I., Harrison L.I., Machacek J.H., Cline A.C., Stampone P.A. Beclomethasone relative availability of oral versus inhaled beclomethasone dipropionate from an HFA-134A metered dose inhaler. Biopharm Drug Dispos 1998, 19:297-302.
-
(1998)
Biopharm Drug Dispos
, vol.19
, pp. 297-302
-
-
Soria, I.1
Harrison, L.I.2
Machacek, J.H.3
Cline, A.C.4
Stampone, P.A.5
-
15
-
-
33748779835
-
Effects of inhaled steroids on growth, bone metabolism, and adrenal function
-
Allen D.B. Effects of inhaled steroids on growth, bone metabolism, and adrenal function. Adv Pediatr 2006, 53:101-110.
-
(2006)
Adv Pediatr
, vol.53
, pp. 101-110
-
-
Allen, D.B.1
-
16
-
-
23044439607
-
How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids
-
Winkler J., Hochhaus G., Derendorf H. How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids. Proc Am Thorac Soc 2004, 1:356-363.
-
(2004)
Proc Am Thorac Soc
, vol.1
, pp. 356-363
-
-
Winkler, J.1
Hochhaus, G.2
Derendorf, H.3
-
17
-
-
0032589989
-
Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects
-
Cave A., Arlett P., Lee E. Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects. Pharmacol Ther 1999, 83:153-179.
-
(1999)
Pharmacol Ther
, vol.83
, pp. 153-179
-
-
Cave, A.1
Arlett, P.2
Lee, E.3
-
18
-
-
74549183716
-
Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: an open-label, single-dose, three-period crossover study in healthy volunteers
-
Nave R., Herzog R., Laurent A., Wingertzahn M.A. Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: an open-label, single-dose, three-period crossover study in healthy volunteers. Clin Ther 2009, 31:2988-2999.
-
(2009)
Clin Ther
, vol.31
, pp. 2988-2999
-
-
Nave, R.1
Herzog, R.2
Laurent, A.3
Wingertzahn, M.A.4
|